RxDoctor Payments Data

Kirby Smith, DO

Family Medicine · Moultrie, GANPI 1801987292

Payments from drug & device makers

$365in general payments, 2019–2025

Across 20 payments — averaging $18.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$67
  • AstraZeneca$56
  • Inspire Medical Systems, Inc.$48
  • AbbVie$46
  • Pfizer$45
  • Boehringer Ingelheim$26
  • plus $77 from 5 others

What the payments were for

  • Food & beverage$365100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$365 in reported general payments places this provider in the 40th percentile of 3,111 family medicine providers in Georgia.

See all family medicine providers in Georgia

Medicare billing

Part B allowed, 2024
$48,556
Medicare patients
180
Services billed
886

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin70$63,902
EliquisApixaban91$58,330
MounjaroTirzepatide34$44,127
OzempicSemaglutide39$43,603
JanuviaSitagliptin Phosphate26$21,415
TrulicityDulaglutide21$20,352
OxycontinOxycodone Hcl24$14,943
LinzessLinaclotide18$14,417
FarxigaDapagliflozin Propanediol15$12,009
Lantus SolostarInsulin Glargine,hum.Rec.Anlog73$9,081
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog11$7,514
XareltoRivaroxaban13$7,012
TradjentaLinagliptin12$6,937
FetzimaLevomilnacipran Hcl11$5,187
Nucynta ErTapentadol Hcl11$4,762

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Tradjenta$26$70,83982 claims
Lilly USA, LLCMounjaro, Trulicity$67$64,47955 claims
PfizerEliquis$45$58,33091 claims
MerckJanuvia$13$21,41526 claims
AbbVieLinzess, Fetzima, Synthroid$46$21,38957 claims
AstraZenecaFarxiga$56$12,00915 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 3,111 family medicine providers in Georgia.

Other family medicine in Moultrie

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →